{"id":45141,"date":"2022-06-16T09:01:27","date_gmt":"2022-06-16T07:01:27","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/slingshot-biosciences-inc-partners-with-kem-en-tec-nordic-a-s-to-distribute-synthetic-cells-throughout-denmark-sweden-norway-finland-and-iceland\/"},"modified":"2022-06-16T09:01:27","modified_gmt":"2022-06-16T07:01:27","slug":"slingshot-biosciences-inc-partners-with-kem-en-tec-nordic-a-s-to-distribute-synthetic-cells-throughout-denmark-sweden-norway-finland-and-iceland","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/slingshot-biosciences-inc-partners-with-kem-en-tec-nordic-a-s-to-distribute-synthetic-cells-throughout-denmark-sweden-norway-finland-and-iceland\/","title":{"rendered":"Slingshot Biosciences, Inc. Partners With Kem-En-Tec Nordic A\/S to Distribute Synthetic Cells Throughout Denmark, Sweden, Norway, Finland, and Iceland"},"content":{"rendered":"<div>\n<p>EMERYVILLE, Calif.&#8211;(BUSINESS WIRE)&#8211;SLINGSHOT BIOSCIENCES, INC. the makers of synthetic cells that bring consistent precision and accurate control to replace inconsistent blood and tissue controls for use in flow cytometry and other biotech markets, today announced they have extended their distribution channel through a new agreement with Kem-En-Tec Nordic A\/S, Provider of Competent Bioscience products to the Nordic laboratories since 1987.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220614006014\/en\/1486805\/5\/primary_full_%282%29.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220614006014\/en\/1486805\/21\/primary_full_%282%29.jpg\"><\/a><\/p>\n<p>\nThe agreement entitles Kem-En-Tec Nordic A\/S to the right to distribute and resell Slingshot Bio\u2019s products in Denmark, Sweden, Norway, Finland, and Iceland. Through Kem-En-Tec Nordic A\/S\u2019s network of customers, Slingshot Bio will be able to establish its presence in the Nordic market with the well-established presence and expertise of Kem-En-Tec Nordic A\/S which has been selling into flow cytometry for many years.\n<\/p>\n<p>\n\u201c<i>Kem-En-Tec Nordic A\/S\u2019s <\/i><i>network will provide us with the market penetration needed to reach our full sales potential. Slingshot Biosciences has considered many distribution partners and we are confident that Kem-En-Tec Nordic A\/S\u2019s extensive knowledge in the field, prominent presence, and large customer base will help us leverage our position in the flow cytometry market,<\/i>\u201d said Jeffrey Kim, CEO &amp; Founder.\n<\/p>\n<p>\nSlingshot Bio\u2019s synthetic cellular controls provide consistent, precise, and accurate control for research users in the flow cytometry space by mimicking blood properties as detected by flow cytometry. The ability to manufacture consistent controls for flow cytometry has been missing for decades and is now accurately reproducible with Slingshot Bio\u2019s unique manufacturing platform. \u201cKem-En-Tec Nordic strongly believes that the innovative synthetic cell controls from Slingshot will be widely adopted by researchers using flow cytometry in all the Nordic countries,\u201d said Henrik Tind Nielsen, CCO &amp; Co-Owner at Kem-En-Tec Nordic.\n<\/p>\n<p>\nAbout Slingshot Biosciences, Inc.\n<\/p>\n<p>\nFounded in 2012, Slingshot Biosciences is a fast-growing life sciences company with a platform technology and paradigm-shifting mission to make synthetic cells the gold standard for all cell-based applications\u2014including diagnostics, and adoptive cell therapy development and instrument calibration. Learn more at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.slingshotbio.com&amp;esheet=52749906&amp;newsitemid=20220614006014&amp;lan=en-US&amp;anchor=www.slingshotbio.com&amp;index=1&amp;md5=f059b5d82ad538c63093c804c279865e\" rel=\"nofollow noopener\" shape=\"rect\">www.slingshotbio.com<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<b>Slingshot Biosciences, Inc.<br \/>\n<br \/><i>The Synthetic Cell Company<\/i><\/b><br \/><b>1250 45<sup>th<\/sup> St. Suite 330<br \/>\n<br \/>Emeryville, CA 94608<br \/>\n<br \/>510-770-6806<br \/>\n<br \/><a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.slingshotbio.com&amp;esheet=52749906&amp;newsitemid=20220614006014&amp;lan=en-US&amp;anchor=www.slingshotbio.com&amp;index=2&amp;md5=7eac0acb45c7471ae401cb9860323bbf\" rel=\"nofollow noopener\" shape=\"rect\">www.slingshotbio.com<\/a><\/b>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>EMERYVILLE, Calif.&#8211;(BUSINESS WIRE)&#8211;SLINGSHOT BIOSCIENCES, INC. the makers of synthetic cells that bring consistent precision and accurate control to replace inconsistent blood and tissue controls for use in flow cytometry and other biotech markets, today announced they have extended their distribution channel through a new agreement with Kem-En-Tec Nordic A\/S, Provider of Competent Bioscience products to &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/slingshot-biosciences-inc-partners-with-kem-en-tec-nordic-a-s-to-distribute-synthetic-cells-throughout-denmark-sweden-norway-finland-and-iceland\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-45141","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Slingshot Biosciences, Inc. Partners With Kem-En-Tec Nordic A\/S to Distribute Synthetic Cells Throughout Denmark, Sweden, Norway, Finland, and Iceland - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/slingshot-biosciences-inc-partners-with-kem-en-tec-nordic-a-s-to-distribute-synthetic-cells-throughout-denmark-sweden-norway-finland-and-iceland\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Slingshot Biosciences, Inc. Partners With Kem-En-Tec Nordic A\/S to Distribute Synthetic Cells Throughout Denmark, Sweden, Norway, Finland, and Iceland - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"EMERYVILLE, Calif.&#8211;(BUSINESS WIRE)&#8211;SLINGSHOT BIOSCIENCES, INC. the makers of synthetic cells that bring consistent precision and accurate control to replace inconsistent blood and tissue controls for use in flow cytometry and other biotech markets, today announced they have extended their distribution channel through a new agreement with Kem-En-Tec Nordic A\/S, Provider of Competent Bioscience products to ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/slingshot-biosciences-inc-partners-with-kem-en-tec-nordic-a-s-to-distribute-synthetic-cells-throughout-denmark-sweden-norway-finland-and-iceland\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-06-16T07:01:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220614006014\/en\/1486805\/21\/primary_full_%282%29.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/slingshot-biosciences-inc-partners-with-kem-en-tec-nordic-a-s-to-distribute-synthetic-cells-throughout-denmark-sweden-norway-finland-and-iceland\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/slingshot-biosciences-inc-partners-with-kem-en-tec-nordic-a-s-to-distribute-synthetic-cells-throughout-denmark-sweden-norway-finland-and-iceland\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Slingshot Biosciences, Inc. Partners With Kem-En-Tec Nordic A\\\/S to Distribute Synthetic Cells Throughout Denmark, Sweden, Norway, Finland, and Iceland\",\"datePublished\":\"2022-06-16T07:01:27+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/slingshot-biosciences-inc-partners-with-kem-en-tec-nordic-a-s-to-distribute-synthetic-cells-throughout-denmark-sweden-norway-finland-and-iceland\\\/\"},\"wordCount\":373,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/slingshot-biosciences-inc-partners-with-kem-en-tec-nordic-a-s-to-distribute-synthetic-cells-throughout-denmark-sweden-norway-finland-and-iceland\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220614006014\\\/en\\\/1486805\\\/21\\\/primary_full_%282%29.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/slingshot-biosciences-inc-partners-with-kem-en-tec-nordic-a-s-to-distribute-synthetic-cells-throughout-denmark-sweden-norway-finland-and-iceland\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/slingshot-biosciences-inc-partners-with-kem-en-tec-nordic-a-s-to-distribute-synthetic-cells-throughout-denmark-sweden-norway-finland-and-iceland\\\/\",\"name\":\"Slingshot Biosciences, Inc. Partners With Kem-En-Tec Nordic A\\\/S to Distribute Synthetic Cells Throughout Denmark, Sweden, Norway, Finland, and Iceland - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/slingshot-biosciences-inc-partners-with-kem-en-tec-nordic-a-s-to-distribute-synthetic-cells-throughout-denmark-sweden-norway-finland-and-iceland\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/slingshot-biosciences-inc-partners-with-kem-en-tec-nordic-a-s-to-distribute-synthetic-cells-throughout-denmark-sweden-norway-finland-and-iceland\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220614006014\\\/en\\\/1486805\\\/21\\\/primary_full_%282%29.jpg\",\"datePublished\":\"2022-06-16T07:01:27+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/slingshot-biosciences-inc-partners-with-kem-en-tec-nordic-a-s-to-distribute-synthetic-cells-throughout-denmark-sweden-norway-finland-and-iceland\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/slingshot-biosciences-inc-partners-with-kem-en-tec-nordic-a-s-to-distribute-synthetic-cells-throughout-denmark-sweden-norway-finland-and-iceland\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/slingshot-biosciences-inc-partners-with-kem-en-tec-nordic-a-s-to-distribute-synthetic-cells-throughout-denmark-sweden-norway-finland-and-iceland\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220614006014\\\/en\\\/1486805\\\/21\\\/primary_full_%282%29.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220614006014\\\/en\\\/1486805\\\/21\\\/primary_full_%282%29.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/slingshot-biosciences-inc-partners-with-kem-en-tec-nordic-a-s-to-distribute-synthetic-cells-throughout-denmark-sweden-norway-finland-and-iceland\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Slingshot Biosciences, Inc. Partners With Kem-En-Tec Nordic A\\\/S to Distribute Synthetic Cells Throughout Denmark, Sweden, Norway, Finland, and Iceland\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Slingshot Biosciences, Inc. Partners With Kem-En-Tec Nordic A\/S to Distribute Synthetic Cells Throughout Denmark, Sweden, Norway, Finland, and Iceland - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/slingshot-biosciences-inc-partners-with-kem-en-tec-nordic-a-s-to-distribute-synthetic-cells-throughout-denmark-sweden-norway-finland-and-iceland\/","og_locale":"en_US","og_type":"article","og_title":"Slingshot Biosciences, Inc. Partners With Kem-En-Tec Nordic A\/S to Distribute Synthetic Cells Throughout Denmark, Sweden, Norway, Finland, and Iceland - Pharma Trend","og_description":"EMERYVILLE, Calif.&#8211;(BUSINESS WIRE)&#8211;SLINGSHOT BIOSCIENCES, INC. the makers of synthetic cells that bring consistent precision and accurate control to replace inconsistent blood and tissue controls for use in flow cytometry and other biotech markets, today announced they have extended their distribution channel through a new agreement with Kem-En-Tec Nordic A\/S, Provider of Competent Bioscience products to ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/slingshot-biosciences-inc-partners-with-kem-en-tec-nordic-a-s-to-distribute-synthetic-cells-throughout-denmark-sweden-norway-finland-and-iceland\/","og_site_name":"Pharma Trend","article_published_time":"2022-06-16T07:01:27+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220614006014\/en\/1486805\/21\/primary_full_%282%29.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/slingshot-biosciences-inc-partners-with-kem-en-tec-nordic-a-s-to-distribute-synthetic-cells-throughout-denmark-sweden-norway-finland-and-iceland\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/slingshot-biosciences-inc-partners-with-kem-en-tec-nordic-a-s-to-distribute-synthetic-cells-throughout-denmark-sweden-norway-finland-and-iceland\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Slingshot Biosciences, Inc. Partners With Kem-En-Tec Nordic A\/S to Distribute Synthetic Cells Throughout Denmark, Sweden, Norway, Finland, and Iceland","datePublished":"2022-06-16T07:01:27+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/slingshot-biosciences-inc-partners-with-kem-en-tec-nordic-a-s-to-distribute-synthetic-cells-throughout-denmark-sweden-norway-finland-and-iceland\/"},"wordCount":373,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/slingshot-biosciences-inc-partners-with-kem-en-tec-nordic-a-s-to-distribute-synthetic-cells-throughout-denmark-sweden-norway-finland-and-iceland\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220614006014\/en\/1486805\/21\/primary_full_%282%29.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/slingshot-biosciences-inc-partners-with-kem-en-tec-nordic-a-s-to-distribute-synthetic-cells-throughout-denmark-sweden-norway-finland-and-iceland\/","url":"https:\/\/pharma-trend.com\/en\/slingshot-biosciences-inc-partners-with-kem-en-tec-nordic-a-s-to-distribute-synthetic-cells-throughout-denmark-sweden-norway-finland-and-iceland\/","name":"Slingshot Biosciences, Inc. Partners With Kem-En-Tec Nordic A\/S to Distribute Synthetic Cells Throughout Denmark, Sweden, Norway, Finland, and Iceland - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/slingshot-biosciences-inc-partners-with-kem-en-tec-nordic-a-s-to-distribute-synthetic-cells-throughout-denmark-sweden-norway-finland-and-iceland\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/slingshot-biosciences-inc-partners-with-kem-en-tec-nordic-a-s-to-distribute-synthetic-cells-throughout-denmark-sweden-norway-finland-and-iceland\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220614006014\/en\/1486805\/21\/primary_full_%282%29.jpg","datePublished":"2022-06-16T07:01:27+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/slingshot-biosciences-inc-partners-with-kem-en-tec-nordic-a-s-to-distribute-synthetic-cells-throughout-denmark-sweden-norway-finland-and-iceland\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/slingshot-biosciences-inc-partners-with-kem-en-tec-nordic-a-s-to-distribute-synthetic-cells-throughout-denmark-sweden-norway-finland-and-iceland\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/slingshot-biosciences-inc-partners-with-kem-en-tec-nordic-a-s-to-distribute-synthetic-cells-throughout-denmark-sweden-norway-finland-and-iceland\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220614006014\/en\/1486805\/21\/primary_full_%282%29.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220614006014\/en\/1486805\/21\/primary_full_%282%29.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/slingshot-biosciences-inc-partners-with-kem-en-tec-nordic-a-s-to-distribute-synthetic-cells-throughout-denmark-sweden-norway-finland-and-iceland\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Slingshot Biosciences, Inc. Partners With Kem-En-Tec Nordic A\/S to Distribute Synthetic Cells Throughout Denmark, Sweden, Norway, Finland, and Iceland"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/45141","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=45141"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/45141\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=45141"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=45141"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=45141"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}